Advancing Heart Transplantation: The Role of the Lumped Parameter Model

By Rene Pretorius

March 27, 2025

How can a new model improve heart transplantation? A recently published article (linked below) discusses the development of a lumped parameter model (LPM) for evaluating cardiac function in ex vivo heart perfusion. This model aims to provide a quantitative and objective assessment of donor heart ...
Addressing Cancer Care Disparities in Europe: Insights from the 2025 Comparator Report
The "Comparator Report on Cancer in Europe 2025" analyzes the landscape of cancer care across Europe. It highlights cancer care disparities persisting in different European regions and cancer types. While advances in treatment exist, many patients still struggle to access timely and effective car...
Nano-Radiopharmaceuticals for Colon Cancer Treatment

By Crystal Lubbe

March 26, 2025

Are we on the brink of an innovation in colon cancer treatment?  This article discusses the emerging role of nano-radiopharmaceuticals for colon cancer in the diagnosis and treatment of this disease. These innovative agents combine nanotechnology with radiopharmaceuticals to enhance targeted drug...
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
As global healthcare systems grow more budget-focused, complex, and dynamic, pharma companies must evolve their value and access strategies accordingly. Systems-thinking-in-pharmaceutical-access offers a
HIV Colorectal Cancer Survival
Are we providing sufficient support for HIV-positive colorectal cancer patients? This meta-analysis investigates the impact of HIV colorectal cancer survival on overall survival (OS) in colorectal cancer (CRC) patients after surgery. It reveals that HIV-positive patients have significantly poorer...
Global Initiative Launches Access to Essential Childhood Cancer Medicines

By João L. Carapinha

March 25, 2025

The World Health Organization (WHO) and St. Jude Children's Research Hospital have launched a major effort to distribute essential childhood cancer medicines. This initiative is part of a new Global Platform targeting low- and middle-income countries (LMICs). It aims to deliver a consistent suppl...

Search By Category

Latest

Advancing Heart Transplantation: The Role of the Lumped Parameter Model

By Rene Pretorius

March 27, 2025

How can a new model improve heart transplantation? A recently published article (linked below) discusses the development of a lumped parameter model (LPM) for evaluating cardiac function in ex vivo heart perfusion. This model aims to provide a quantitative and objective assessment of donor heart ...

Latest

Addressing Cancer Care Disparities in Europe: Insights from the 2025 Comparator Report
The "Comparator Report on Cancer in Europe 2025" analyzes the landscape of cancer care across Europe. It highlights cancer care disparities persisting in different European regions and cancer types. While advances in treatment exist, many patients still struggle to access timely and effective car...

Latest

Nano-Radiopharmaceuticals for Colon Cancer Treatment

By Crystal Lubbe

March 26, 2025

Are we on the brink of an innovation in colon cancer treatment?  This article discusses the emerging role of nano-radiopharmaceuticals for colon cancer in the diagnosis and treatment of this disease. These innovative agents combine nanotechnology with radiopharmaceuticals to enhance targeted drug...

Latest

Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
As global healthcare systems grow more budget-focused, complex, and dynamic, pharma companies must evolve their value and access strategies accordingly. Systems-thinking-in-pharmaceutical-access offers a

Global Updates

Advancing Heart Transplantation: The Role of the Lumped Parameter Model

By Rene Pretorius

March 27, 2025

How can a new model improve heart transplantation? A recently published article (linked below) discusses the development of a lumped parameter model (LPM) for evaluating cardiac function in ex vivo heart perfusion. This model aims to provide a quantitative and objective assessment of donor heart ...

Global Updates

Nano-Radiopharmaceuticals for Colon Cancer Treatment

By Crystal Lubbe

March 26, 2025

Are we on the brink of an innovation in colon cancer treatment?  This article discusses the emerging role of nano-radiopharmaceuticals for colon cancer in the diagnosis and treatment of this disease. These innovative agents combine nanotechnology with radiopharmaceuticals to enhance targeted drug...

Global Updates

HIV Colorectal Cancer Survival
Are we providing sufficient support for HIV-positive colorectal cancer patients? This meta-analysis investigates the impact of HIV colorectal cancer survival on overall survival (OS) in colorectal cancer (CRC) patients after surgery. It reveals that HIV-positive patients have significantly poorer...

Global Updates

Global Initiative Launches Access to Essential Childhood Cancer Medicines

By João L. Carapinha

March 25, 2025

The World Health Organization (WHO) and St. Jude Children's Research Hospital have launched a major effort to distribute essential childhood cancer medicines. This initiative is part of a new Global Platform targeting low- and middle-income countries (LMICs). It aims to deliver a consistent suppl...

Europe

cancer care disparities
     

Addressing Cancer Care Disparities in Europe: Insights from the 2025 Comparator Report

💡 Are cancer care disparities in Europe jeopardizing patient outcomes?

The “Comparator Report on Cancer in Europe 2025” reveals a striking contrast in access to cancer treatment across the continent, highlighting not just the rising incidence of cases but also the sobering challenges faced by patients—especially in lower-income regions. With healthcare costs soaring and access to innovative medicines lagging, it’s clear we need a shift towards more equitable healthcare policies.

Dive into the full report to better understand these critical insights and their implications for improving cancer care accessibility!

#SyenzaNews #oncology #healthcarepolicy #HealthEconomics

Middle East

liquid biopsy colorectal cancer
     

Liquid Biopsy Colorectal Cancer Screening Expands in Abu Dhabi

🌟 Is liquid biopsy the future of colorectal cancer screening?

Abu Dhabi is pioneering a transformative approach to colorectal cancer detection with the introduction of the innovative liquid biopsy Shield Test, designed to enhance early detection rates while working alongside traditional methods. This exciting development not only promises to improve patient outcomes but also has the potential to set new standards for health economics and market access.

Curious how this will reshape screening practices? Explore the full article to learn more!

#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess

Sub-Saharan Africa

HIV colorectal cancer survival
       

HIV Colorectal Cancer Survival

🩺 Are we doing enough to support HIV-positive colorectal cancer patients?

A recent meta-analysis has revealed that HIV-positive patients face significantly poorer overall survival after colorectal cancer surgery compared to their HIV-negative counterparts, with a startling hazard ratio of 3.12. This underscores the urgent need for tailored postoperative management strategies to enhance outcomes for this vulnerable group.

Dive into the key findings and understand the implications for healthcare policies and practices.

#SyenzaNews #HealthEconomics #oncology #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.